Hanssen J, van der Wal R, Mahdad R, Keizer S, Delfos N, van der Lugt J
Antimicrob Agents Chemother. 2024; 68(12):e0123224.
PMID: 39535202
PMC: 11619448.
DOI: 10.1128/aac.01232-24.
Ferreira L, Pos E, Nogueira D, Ferreira F, Sousa R, Abreu M
Front Microbiol. 2024; 15:1435720.
PMID: 39268543
PMC: 11391936.
DOI: 10.3389/fmicb.2024.1435720.
Mikzinski P, Kraus K, Widelski J, Paluch E
Microorganisms. 2024; 12(6).
PMID: 38930580
PMC: 11205407.
DOI: 10.3390/microorganisms12061198.
Nicholls P, Clark J, Gu Liu C, Terwilliger A, Maresso A
Infect Immun. 2023; 91(8):e0006523.
PMID: 37404162
PMC: 10429645.
DOI: 10.1128/iai.00065-23.
Rottier W, Seidelman J, Wouthuyzen-Bakker M
Arthroplasty. 2023; 5(1):10.
PMID: 36864531
PMC: 9979546.
DOI: 10.1186/s42836-023-00169-4.
prosthetic joint-infection outcomes: Prospective, observational study on 43 patients.
Prie H, Meyssonnier V, Kerroumi Y, Heym B, Lidove O, Marmor S
Front Med (Lausanne). 2022; 9:1039596.
PMID: 36569155
PMC: 9774483.
DOI: 10.3389/fmed.2022.1039596.
Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France.
Cerioli M, Batailler C, Conrad A, Roux S, Perpoint T, Becker A
Front Med (Lausanne). 2020; 7:513242.
PMID: 33195289
PMC: 7649271.
DOI: 10.3389/fmed.2020.513242.
Recommendations for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus From an International Expert Group.
Depypere M, Kuehl R, Metsemakers W, Senneville E, McNally M, Obremskey W
J Orthop Trauma. 2019; 34(1):30-41.
PMID: 31567902
PMC: 6903362.
DOI: 10.1097/BOT.0000000000001626.
Treatment of Prosthetic Joint Infection with Debridement, Antibiotics and Irrigation with Implant Retention - a Narrative Review.
Sousa R, Abreu M
J Bone Jt Infect. 2018; 3(3):108-117.
PMID: 30013891
PMC: 6043472.
DOI: 10.7150/jbji.24285.
Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions.
Cabral D, Wurster J, Belenky P
Pharmaceuticals (Basel). 2018; 11(1).
PMID: 29389876
PMC: 5874710.
DOI: 10.3390/ph11010014.
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
Maurice N, Bedi B, Sadikot R
Am J Respir Cell Mol Biol. 2018; 58(4):428-439.
PMID: 29372812
PMC: 5894500.
DOI: 10.1165/rcmb.2017-0321TR.
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.
Lebeaux D, Ghigo J, Beloin C
Microbiol Mol Biol Rev. 2014; 78(3):510-43.
PMID: 25184564
PMC: 4187679.
DOI: 10.1128/MMBR.00013-14.
Applying insights from biofilm biology to drug development - can a new approach be developed?.
Bjarnsholt T, Ciofu O, Molin S, Givskov M, Hoiby N
Nat Rev Drug Discov. 2013; 12(10):791-808.
PMID: 24080700
DOI: 10.1038/nrd4000.
Analysis of bacterial biofilms using NMR-based metabolomics.
Zhang B, Powers R
Future Med Chem. 2012; 4(10):1273-306.
PMID: 22800371
PMC: 3564560.
DOI: 10.4155/fmc.12.59.
Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
Martinez-Pastor J, Vilchez F, Pitart C, Sierra J, Soriano A
Eur J Clin Microbiol Infect Dis. 2010; 29(8):1039-41.
PMID: 20473541
DOI: 10.1007/s10096-010-0950-y.
Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance.
Sawasdidoln C, Taweechaisupapong S, Sermswan R, Tattawasart U, Tungpradabkul S, Wongratanacheewin S
PLoS One. 2010; 5(2):e9196.
PMID: 20169199
PMC: 2820546.
DOI: 10.1371/journal.pone.0009196.
Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis.
Martinez-Pastor J, Munoz-Mahamud E, Vilchez F, Garcia-Ramiro S, Bori G, Sierra J
Antimicrob Agents Chemother. 2009; 53(11):4772-7.
PMID: 19687237
PMC: 2772308.
DOI: 10.1128/AAC.00188-09.
Signals, regulatory networks, and materials that build and break bacterial biofilms.
Karatan E, Watnick P
Microbiol Mol Biol Rev. 2009; 73(2):310-47.
PMID: 19487730
PMC: 2698413.
DOI: 10.1128/MMBR.00041-08.
Assessing the contamination potential of freshly extracted Escherichia coli biofilm cells by impedancemetry.
Caubet R, Pedarros-Caubet F, Quataert Y, Lescure A, Moreau J, Ellison W
Microb Ecol. 2006; 52(2):239-43.
PMID: 16897295
DOI: 10.1007/s00248-006-9118-9.
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.
Borriello G, Werner E, Roe F, Kim A, Ehrlich G, Stewart P
Antimicrob Agents Chemother. 2004; 48(7):2659-64.
PMID: 15215123
PMC: 434183.
DOI: 10.1128/AAC.48.7.2659-2664.2004.